Repligen acquires Bio-Flex Solutions and Newton T&M for cash; terms undisclosed

REPLIGEN CORP

Acquired all outstanding equity interests in Bio-Flex Solutions and Newton T&M effective Dec 16, 2021.
Purchase price is cash consideration; no dollar amount disclosed in the filing.
Bio-Flex Solutions specializes in single-use flexible containers and tubing assemblies for biopharma.
Transaction complements Repligen's fluid management portfolio; investor presentation provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.